Measles cases rise in Texas and New Mexico

Dr. Scott Gottlieb, former FDA commissioner and current board member at Pfizer, discussed the recent measles outbreak during an interview on "Face the Nation." He mentioned that measles is now reported in 18 states, predominantly in Texas and New Mexico, with a notable increase in infections among children. Gottlieb reassured adults who have been vaccinated that they should be protected. Those who received two doses of the measles vaccine as children typically do not need a booster. However, he advised healthcare workers caring for measles patients to consider getting an additional booster. For young children, there is a window of vulnerability between six and twelve months where many are unprotected, prompting some recommendations for a first dose of the vaccine during this time. The discussion also touched on alternative treatments suggested by HHS Secretary Robert F. Kennedy Jr. These include Budesonide, a steroid, and cod liver oil. Gottlieb dismissed these as effective alternatives to vaccination, emphasizing that the best defense against measles is vaccination. He noted that treating severe measles cases may involve steroids or antibiotics but stressed prevention through vaccination remains essential. Gottlieb highlighted the critical need for leadership at the CDC, especially during the current measles outbreak. He mentioned that more cases could arise this year than in the past 25 years. He praised potential CDC director candidates, including Michael Burgess, for their relevant experience in health leadership. The conversation also covered recent funding cuts affecting major health research institutions like Johns Hopkins and Columbia. Gottlieb expressed concern over how these cuts could impact patient care and health research. He reiterated the importance of strategic funding decisions in health-related programs, noting that mistakes can be rectified in website management but not in patient care continuity.